The COVID-19 Drug and Gene Set Library
暂无分享,去创建一个
Kathleen M. Jagodnik | Avi Ma’ayan | Daniel J. Stein | Jason Hom | Allison Bailey | Alexander Lachmann | Daniel J. B. Clarke | Alon Bartal | Maxim V. Kuleshov | Daniel J.B. Clarke | Eryk Kropiwnicki | John E. Evangelista | Minxuan Cheng | Abigail Zhou | Laura B. Ferguson | Daniel J. Stein | Avi Ma’ayan | Alexander Lachmann | L. Ferguson | Alon Bartal | Eryk Kropiwnicki | J. E. Evangelista | Allison Bailey | Jason Hom | Minxuan Cheng | Abigail Zhou
[1] A. Singanayagam,et al. Immunosuppression for hyperinflammation in COVID-19: a double-edged sword? , 2020, The Lancet.
[2] David S. Wishart,et al. DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..
[3] S. Rajasekaran,et al. Analysis of Infected Host Gene Expression Reveals Repurposed Drug Candidates and Time-Dependent Host Response Dynamics for COVID-19 , 2020, bioRxiv.
[4] M. Bjørås,et al. Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19 , 2020, bioRxiv.
[5] Paul Shinn,et al. Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs , 2014, Emerging Microbes & Infections.
[6] Lars Juhl Jensen. Tagger: BeCalm API for rapid named entity recognition , 2017 .
[7] David Shum,et al. Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs , 2020, Antimicrobial Agents and Chemotherapy.
[8] Simon Lin,et al. GeneRIF is a more comprehensive, current and computationally tractable source of gene-disease relationships than OMIM , 2006 .
[9] Yolanda T. Chong,et al. Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-2 , 2020, bioRxiv.
[10] Hualiang Jiang,et al. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors , 2020, Nature.
[11] C. Cava,et al. In Silico Discovery of Candidate Drugs against Covid-19 , 2020, Viruses.
[12] Peter G. Schultz,et al. A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals , 2020, bioRxiv.
[13] Zihe Rao,et al. Structure of Mpro from COVID-19 virus and discovery of its inhibitors , 2020, medRxiv.
[14] Andrew D. Rouillard,et al. GEO2Enrichr: browser extension and server app to extract gene sets from GEO and analyze them for biological functions , 2015, Bioinform..
[15] Angela N. Brooks,et al. A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles , 2017, Cell.
[16] George Papadatos,et al. The ChEMBL database in 2017 , 2016, Nucleic Acids Res..
[17] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[18] Kathleen M Jagodnik,et al. Extraction and analysis of signatures from the Gene Expression Omnibus by the crowd , 2016, Nature Communications.
[19] Andrew D. Rouillard,et al. The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins , 2016, Database J. Biol. Databases Curation.
[20] Denis Torre,et al. BioJupies: Automated Generation of Interactive Notebooks for RNA-Seq Data Analysis in the Cloud. , 2018, Cell systems.
[21] Andrew R. Leach,et al. The Global Phosphorylation Landscape of SARS-CoV-2 Infection , 2020, Cell.
[22] Motonori Ota,et al. Knowledge‐based structural models of SARS‐CoV‐2 proteins and their complexes with potential drugs , 2020, FEBS letters.
[23] R. N. Brogden,et al. Mefloquine , 1993, Drugs.
[24] Gaël Varoquaux,et al. Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..
[25] Pierre Geurts,et al. Extremely randomized trees , 2006, Machine Learning.
[26] J. Baell,et al. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. , 2010, Journal of medicinal chemistry.
[27] P. Mehta,et al. COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.
[28] Denis Torre,et al. Geneshot: search engine for ranking genes from arbitrary text queries , 2019, Nucleic Acids Res..
[29] F. Alakwaa. Repurposing Didanosine as a Potential Treatment for COVID-19 Using Single-Cell RNA Sequencing Data , 2020, mSystems.
[30] Jianyang Zeng,et al. A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19 , 2020, bioRxiv.
[31] B. Oakley,et al. Faculty Opinions recommendation of A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. , 2020, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.
[32] R. Albrecht,et al. SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems , 2020, bioRxiv.
[33] Avi Ma'ayan,et al. Drug-induced adverse events prediction with the LINCS L1000 data , 2016, Bioinform..
[34] In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication , 2020, Scientific Reports.
[35] Christopher. Simons,et al. Machine learning with Python , 2017 .
[36] Nikos Vasilakis,et al. A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection. , 2016, Cell host & microbe.
[37] C. Mélot,et al. Improvement in ventilation-perfusion matching by almitrine in COPD. , 1983, Chest.
[38] Bruno Coutard,et al. In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication , 2020, Scientific Reports.
[39] Jennifer L. Bell,et al. Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report , 2020, medRxiv.
[40] B. Russ,et al. Homology Modeling of TMPRSS2 Yields Candidate Drugs That May Inhibit Entry of SARS-CoV-2 into Human Cells , 2020 .
[41] Kathleen M Jagodnik,et al. Massive mining of publicly available RNA-seq data from human and mouse , 2017, Nature Communications.
[42] Constancio González,et al. Effects of almitrine bismesylate on the ionic currents of chemoreceptor cells from the carotid body. , 1998, Molecular pharmacology.
[43] R. Schwartz,et al. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 , 2020, Cell.
[44] Trey Ideker,et al. A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing , 2020, bioRxiv.
[45] S. Rajasekaran,et al. Reversal of Infected Host Gene Expression Identifies Repurposed Drug Candidates for COVID-19. , 2020, bioRxiv : the preprint server for biology.
[46] L. Guenther,et al. Acitretin Use in Dermatology , 2017, Journal of cutaneous medicine and surgery.
[47] Avi Ma'ayan,et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool , 2013, BMC Bioinformatics.
[48] M. Sherman,et al. A Preliminary Report , 1953 .
[49] Benjamin J. Polacco,et al. A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing , 2020, Nature.
[51] W. Vischer,et al. Lamprene (clofazimine) in leprosy. Basic information. , 1979, Leprosy review.